Search

Kevin E. Weddington

Examiner (ID: 6966)

Most Active Art Unit
1614
Art Unit(s)
1614, 1205, 1629, 2899
Total Applications
3386
Issued Applications
2180
Pending Applications
434
Abandoned Applications
815

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5844626 [patent_doc_number] => 20060122244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Use of compounds' [patent_app_type] => utility [patent_app_number] => 11/339188 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5872 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122244.pdf [firstpage_image] =>[orig_patent_app_number] => 11339188 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/339188
Use of compounds Jan 24, 2006 Abandoned
Array ( [id] => 8374964 [patent_doc_number] => 08257755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same' [patent_app_type] => utility [patent_app_number] => 11/795638 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 7517 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11795638 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795638
Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same Jan 19, 2006 Issued
Array ( [id] => 5889872 [patent_doc_number] => 20060276416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods and compositions for treating flushing and drug induced weight gain' [patent_app_type] => utility [patent_app_number] => 11/336258 [patent_app_country] => US [patent_app_date] => 2006-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 74949 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276416.pdf [firstpage_image] =>[orig_patent_app_number] => 11336258 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/336258
Methods and compositions for treating flushing and drug induced weight gain Jan 19, 2006 Abandoned
Array ( [id] => 5349962 [patent_doc_number] => 20090005323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Cathepsin K Inhibitors and Obesity' [patent_app_type] => utility [patent_app_number] => 11/795447 [patent_app_country] => US [patent_app_date] => 2006-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10656 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005323.pdf [firstpage_image] =>[orig_patent_app_number] => 11795447 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795447
Cathepsin K Inhibitors and Obesity Jan 16, 2006 Abandoned
Array ( [id] => 159391 [patent_doc_number] => 07674790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Processes of making and using pharmaceutical formulations of antineoplastic agents' [patent_app_type] => utility [patent_app_number] => 11/332721 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5671 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674790.pdf [firstpage_image] =>[orig_patent_app_number] => 11332721 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/332721
Processes of making and using pharmaceutical formulations of antineoplastic agents Jan 12, 2006 Issued
Array ( [id] => 5673024 [patent_doc_number] => 20060178379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Methods of treating patients suffering from movement disorders' [patent_app_type] => utility [patent_app_number] => 11/326414 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19349 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178379.pdf [firstpage_image] =>[orig_patent_app_number] => 11326414 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/326414
Administering adenosine A2A receptor antagonist to reduce or suppress side effects of parkinson's disease therapy Jan 5, 2006 Issued
Array ( [id] => 5632357 [patent_doc_number] => 20060148827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Methods of treating patients suffering from movement disorders' [patent_app_type] => utility [patent_app_number] => 11/326516 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20472 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148827.pdf [firstpage_image] =>[orig_patent_app_number] => 11326516 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/326516
Methods of treating patients suffering from movement disorders Jan 5, 2006 Issued
Array ( [id] => 4553165 [patent_doc_number] => 07820656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Pharmaceutical composition comprising N-aryl N′ morpholino/piperidino thiocarbamide derivatives for treating type II diabetes' [patent_app_type] => utility [patent_app_number] => 11/315696 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4923 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820656.pdf [firstpage_image] =>[orig_patent_app_number] => 11315696 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/315696
Pharmaceutical composition comprising N-aryl N′ morpholino/piperidino thiocarbamide derivatives for treating type II diabetes Dec 21, 2005 Issued
Array ( [id] => 5527791 [patent_doc_number] => 20090197868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => '5ht2c receptor modulator compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/793941 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30426 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197868.pdf [firstpage_image] =>[orig_patent_app_number] => 11793941 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793941
5ht2C receptor modulator compositions Dec 20, 2005 Issued
Array ( [id] => 5011509 [patent_doc_number] => 20070281988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Combination Therapy for Vascular Complications Associated with Hyperglycemia' [patent_app_type] => utility [patent_app_number] => 11/720087 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3768 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20070281988.pdf [firstpage_image] =>[orig_patent_app_number] => 11720087 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/720087
Combination Therapy for Vascular Complications Associated with Hyperglycemia Dec 15, 2005 Abandoned
Array ( [id] => 5865067 [patent_doc_number] => 20060099197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Probiotic, lactic acid-producing bacteria and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/305507 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19468 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099197.pdf [firstpage_image] =>[orig_patent_app_number] => 11305507 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/305507
Probiotic, lactic acid-producing bacteria and uses thereof Dec 15, 2005 Issued
Array ( [id] => 5866145 [patent_doc_number] => 20060100276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Method of treating neutrophil-related diseases with topical anesthetics' [patent_app_type] => utility [patent_app_number] => 11/300846 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8147 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100276.pdf [firstpage_image] =>[orig_patent_app_number] => 11300846 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/300846
Method of treating neutrophil-related diseases with topical anesthetics Dec 14, 2005 Abandoned
Array ( [id] => 5016719 [patent_doc_number] => 20070259928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Medicinal Composition for Treating Diabetes' [patent_app_type] => utility [patent_app_number] => 11/792879 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4398 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259928.pdf [firstpage_image] =>[orig_patent_app_number] => 11792879 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792879
Medicinal Composition for Treating Diabetes Dec 11, 2005 Abandoned
Array ( [id] => 5304093 [patent_doc_number] => 20090298745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => ' Treatment of Diabetes with Glycogen Phosphorylase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/792186 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10925 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298745.pdf [firstpage_image] =>[orig_patent_app_number] => 11792186 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792186
Treatment of Diabetes with Glycogen Phosphorylase Inhibitors Dec 1, 2005 Abandoned
Array ( [id] => 4903633 [patent_doc_number] => 20080113046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients' [patent_app_type] => utility [patent_app_number] => 11/792060 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2387 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113046.pdf [firstpage_image] =>[orig_patent_app_number] => 11792060 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792060
Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients Dec 1, 2005 Abandoned
Array ( [id] => 5716202 [patent_doc_number] => 20060079565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Amino acid composition and supplementary liquid containing the same' [patent_app_type] => utility [patent_app_number] => 11/289383 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5075 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079565.pdf [firstpage_image] =>[orig_patent_app_number] => 11289383 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/289383
Amino acid composition and supplementary liquid containing the same Nov 29, 2005 Issued
Array ( [id] => 5716117 [patent_doc_number] => 20060079480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Novel antifolate combination therapies' [patent_app_type] => utility [patent_app_number] => 11/288807 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5557 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079480.pdf [firstpage_image] =>[orig_patent_app_number] => 11288807 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/288807
Novel antifolate combination therapies Nov 28, 2005 Abandoned
Array ( [id] => 142146 [patent_doc_number] => 07687544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'Method of using catalpic acid to treat type 2 diabetes and associated disorders' [patent_app_type] => utility [patent_app_number] => 11/287588 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8021 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687544.pdf [firstpage_image] =>[orig_patent_app_number] => 11287588 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/287588
Method of using catalpic acid to treat type 2 diabetes and associated disorders Nov 27, 2005 Issued
Array ( [id] => 5655290 [patent_doc_number] => 20060141025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Methods and compositions for delivery of catecholic butanes for treatment of tumors' [patent_app_type] => utility [patent_app_number] => 11/284111 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25558 [patent_no_of_claims] => 96 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141025.pdf [firstpage_image] =>[orig_patent_app_number] => 11284111 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/284111
Methods for delivery of catecholic butanes for treatment of tumors Nov 20, 2005 Issued
Array ( [id] => 4461013 [patent_doc_number] => 07879865 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Treatment of cancer of the brain using histone deacetylase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/282420 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1989 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879865.pdf [firstpage_image] =>[orig_patent_app_number] => 11282420 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282420
Treatment of cancer of the brain using histone deacetylase inhibitors Nov 17, 2005 Issued
Menu